Mizuho analyst John Roberts raised the firm’s price target on Chemours (CC) to $19 from $16 and keeps an Outperform rating on the shares. The firm recommends the stock, saying per- and polyfluoroalkyl substance settlements “are trending in the right direction.” It cites higher market multiples for the target increase.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC: